Literature DB >> 27322718

A 10-Year Follow-up Survey of Treatment Abandonment of Children With Acute Myeloid Leukemia in Suzhou, China.

Dan Hong1, Chenyan Zhou, Hailong He, Yi Wang, Jun Lu, Shaoyan Hu.   

Abstract

A survey of the clinical data on acute myeloid leukemia (AML) over the past 10 years in the treatment center of Children's Hospital was presented. The aim of the study was to identify the factors influencing the treatment abandonment rate (AR) of AML. Of the 474 AML cases examined, 264 were abandoned (55.7%). The most important factor affecting AR appeared to be the AML subtype-that is, the M3 versus non-M3 (42% vs. 60%). Patient age was observed to be closely related to AR-the older the patients, the lower the AR-and infants had the highest prevalence of abandonment (84.2%). The patient's residential location was markedly correlated to AR, which was almost inversely proportional to the size of the township where the patient came from. From large cities, intermediate and small towns to countryside villages, the AR increased linearly. So was the correlation with health insurance coverage, which decreased in the same way. Sex and karyotypes did not affect AR. In conclusion, the patients' financial burden and the perceived incurability of AML were the 2 leading factors dominating the decision for abandonment in parents and caregivers.

Entities:  

Mesh:

Year:  2016        PMID: 27322718     DOI: 10.1097/MPH.0000000000000601

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Financial toxicity in hematological malignancies: a systematic review.

Authors:  Evguenia Ouchveridze; Rahul Banerjee; Aakash Desai; Muhammad Aziz; Wade Lee-Smith; Hira Mian; Katherine Berger; Brian McClune; Douglas Sborov; Muzaffar Qazilbash; Shaji Kumar; Ghulam Rehman Mohyuddin
Journal:  Blood Cancer J       Date:  2022-04-22       Impact factor: 9.812

2.  Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study.

Authors:  Yixin Hu; Aili Chen; Li Gao; Hailong He; Shuting Jiang; Xinchang Zheng; Peifang Xiao; Jun Lu; Yi Wang; Jie Li; Jianqin Li; Junjie Fan; Yanhua Yao; Jing Ling; Liyan Fan; Shengqin Cheng; Cheng Cheng; Fang Fang; Jian Pan; Qian-Fei Wang; Raul C Ribeiro; Shaoyan Hu
Journal:  Blood Adv       Date:  2021-04-13

3.  Risk Factors and Reasons for Treatment Abandonment for Patients With Esophageal Atresia: A Study From a Tertiary Care Hospital in Beijing, China.

Authors:  Shen Yang; Junmin Liao; Siqi Li; Kaiyun Hua; Peize Wang; Yanan Zhang; Yong Zhao; Yichao Gu; Shuangshuang Li; Jinshi Huang
Journal:  Front Pediatr       Date:  2021-04-27       Impact factor: 3.418

Review 4.  Health-Related and Economic Burden Among Family Caregivers of Patients with Acute Myeloid Leukemia or Hematological Malignancies.

Authors:  Emre Yucel; Shiyu Zhang; Sumeet Panjabi
Journal:  Adv Ther       Date:  2021-09-09       Impact factor: 3.845

5.  Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015-2019 in Guangdong, China.

Authors:  Chunwang Zhan; Zhiming Wu; Lihua Yang; Lihua Yu; Jie Deng; Kiuco Luk; Chongyang Duan; Luwen Zhang
Journal:  BMC Health Serv Res       Date:  2022-02-19       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.